Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cholesterol drugs should not be available OTC, FDA guidance says.

This article was originally published in The Tan Sheet

Executive Summary

HYPERCHOLESTEROLEMIA DRUGS "SHOULD NOT BE SOLD OTC," FDA states in an "guidance for industry" on the "OTC treatment of hypercholesterolemia," released Oct. 2. Issued as a follow-up to the May advisory committee meeting on Bristol-Myers Squibb's Rx-to-OTC switch application for Questran powder for reconstruction, the guidance states that the Center for Drug Evaluation & Research concurs with the advisory committee recommendation that hypercholesterolemia treatment requires both preliminary and ongoing medical management. CDER "therefore believes that drugs for the treatment of hypercholesterolemia should not be sold OTC in the United States."
Advertisement

Related Content

OTC Cholesterol Drugs May Be Revisited By FDA In 2000
OTC Cholesterol Drugs May Be Revisited By FDA In 2000
OTC Cholesterol Drugs May Be Revisited By FDA In 2000
Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer
Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer
Healthcare "Rationing" Not Acceptable Reason For Denying Switches - FDAer

Topics

Advertisement
UsernamePublicRestriction

Register

PS087596

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel